PREDICT (Patient characteristics in Renal cell carcinoma and Daily practice Treatment with Nexavar) global non-interventional study: first interim results

被引：0
|
作者：
Jager, D. [1 ]
Ma, J. H. [2 ]
Korbenfeld, E. [3 ]
Zemanova, M. [4 ]
Leonhartsberger, N. [5 ]
Stauch, K. [6 ]
Boeckenhoff, A. [7 ]
Yu, J. [8 ]
Escudier, B. [9 ]
机构：
[1] Univ Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina
[4] Charles Univ Prague, Prague, Czech Republic
[5] Univ Innsbruck, A-6020 Innsbruck, Austria
[6] Bayer HealthCare, Leverkusen, Germany
[7] Bayer HealthCare, Wuppertal, Germany
[8] Bayer HealthCare, Montville, NJ USA
[9] Inst Gustave Roussy, Villejuif, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71461-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：431 / 432
页数：2
相关论文
共 50 条
  • [21] PREDICT GLOBAL NON-INTERVENTIONAL STUDY: BASELINE CHARACTERISTICS OF RCC PATIENTS TREATED WITH SORAFENIB
    Jaeger, D.
    Ma, J.
    Korbenfeld, E.
    Zemanova, M.
    Leonhartsberger, N.
    Stauch, K.
    Bockenhoff, A.
    Yu, J.
    Mardiak, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 291 - 291
  • [22] SORAFENIB IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) AND BASELINE HYPERTENSION OR DIABETES: SUBANALYSIS OF THE NON-INTERVENTIONAL PREDICT STUDY
    Jaeger, D.
    Guo, J.
    Korbenfeld, E.
    Zemanova, M.
    Leonhartsberger, N.
    Stauch, K.
    Boeckenhoff, A.
    Yu, J.
    Mardiak, J.
    Escudier, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 279 - 280
  • [23] SORAFENIB IN PATIENTS WITH RENAL CELL CARCINOMA AND BRAIN, BONE OR LUNG METASTASES: SUBANALYSIS OF THE NON-INTERVENTIONAL PREDICT STUDY
    Mardiak, J.
    Ma, J.
    Korbenfeld, E.
    Zemanova, M.
    Leonhartsberger, N.
    Stauch, K.
    Boeckenhoff, A.
    Yu, J.
    Escudier, B.
    Jaeger, D.
    ANNALS OF ONCOLOGY, 2012, 23 : 270 - 270
  • [24] Interim analysis of a non-interventional study evaluating the quality of life in second-line treatment of metastatic renal cell carcinoma with everolimus (EVERPRO)
    Bergmann, L.
    Goebell, P. J.
    Kloss, S.
    Schirrmacher-Memel, S.
    Warnack, W.
    Kube, U.
    Scheffler, M.
    Doehn, C.
    Marschner, N.
    Rose, C.
    Herrmann, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 89 - 89
  • [25] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 510 - 510
  • [26] Olaparib in German routine clinical practice - Interim results of the non-interventional study C-PATROL
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    Fasching, P. A.
    El-Balat, A.
    Glowik, R.
    Marme, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [27] 5 years effectiveness of fingolimod in daily clinical practice: results of the non-interventional study PANGAEA
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 372 - 373
  • [28] TOCILIZUMAB ADMINISTERED IN DAILY CLINICAL PRACTICE - FINAL RESULTS OF THE GERMAN NON-INTERVENTIONAL STUDY "ROUTINE"
    Burmester, G. -R.
    von Hinueber, U.
    Richter, C.
    Schwenke, H.
    Guertler, I.
    Kaestner, P.
    Peters, M. A.
    Iking-Konert, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 452 - 452
  • [29] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1590 - 1590
  • [30] Sequential treatment with pazopanib (PAZO) followed by nivolumab (NIVO) in patients with advanced or metastatic renal cell carcinoma (mRCC): Third interim results of the non-interventional study PAZOREAL.
    Boegemann, Martin
    Bedke, Jens
    Schostak, Martin
    Hering-Schubert, Christiane
    Welslau, Manfred
    Schleicher, Jan
    Wolf, Thomas
    Petzoldt, Alexander
    Doehn, Christian
    Grullich, Carsten
    Gruenwald, Viktor
    Steiner, Thomas
    Rogler, Anja
    Hanson, Sven
    Klein, Dunja
    Medinger, Tanja
    Goebell, Peter-Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345